Context Therapeutics Inc. (CNTX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Context Therapeutics Inc. (CNTX) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

CNTX Cash Flow Statement

Context Therapeutics Inc. (CNTX) cash flow statement — 7-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-7.02M	-11.43M	-8.94M	-6.58M	-5.84M	-5.03M	-4.91M	-1.93M	-3.36M	-4.36M	-7.23M	-3.46M	-4.63M	-5.73M	-3.93M	-2.99M	-2.81M	-3.82M	-4.96M	-43.63K
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-20.3%	-127.3%	-82.25%	-240.29%	-73.89%	-15.31%	32.1%	44.14%	27.54%	23.88%	-83.91%	-15.59%	-65.09%	-49.95%	20.8%	-6762%	-34.93%	-122.72%	-2718.74%	-
Net Income	-14.56M	-8.68M	-13.03M	-9.69M	-8.83M	-4.58M	-3.34M	-17.46M	-2.25M	-3.67M	-6.77M	-5.87M	-5.01M	-6.31M	-3.56M	-3.85M	-3.99M	-3.44M	-3.09M	-1.44M
Depreciation & Amortization	6.65K	4.69K	4.07K	4.07K	4.07K	4.05K	2.93K	2.81K	2.57K	2.57K	2.57K	3.09K	3.19K	3.19K	3.19K	3.19K	2.88K	0	0	0
Stock-Based Compensation	528.1K	409.22K	325.17K	323.08K	389.11K	293.72K	231.82K	213K	157.04K	240.01K	256.05K	254.95K	283.1K	282.76K	243.64K	276.52K	241.32K	214.96K	204.38K	161.82K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	294.02K	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	7.36M	31.42K	2.03M	27.46K	26.73K	26.01K	25.32K	14.77M	0	0	-294.02K	7.52K	22.37K	22.07K	21.79K	21.5K	521.22K	14.02K	-18.24K	-124.32K
Working Capital Changes	-357.37K	-3.19M	1.73M	2.76M	2.57M	-774.9K	-1.82M	544.25K	-1.26M	-935.4K	-715.9K	2.15M	71.55K	271.83K	-641.51K	559K	415.91K	-610.92K	-2.06M	1.36M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	822.48K	-67.16K	-187.99K	325K	1.39M	-435.64K	408.25K	461.79K	-1.48M	-337.65K	555.21K	636.95K	-19.41K	273.93K	-558.66K	1.05M	-9.37K	-1.27M	-686.81K	2.13M
Cash from Investing	-4.52M	-37.26K	-2M	0	0	-33.95K	0	-14.76M	0	0	0	0	0	0	0	-500K	-1.84K	-35K	0	0
Capital Expenditures	-18.49K	-37.26K	-2M	0	0	-33.95K	0	-7.32K	0	0	0	0	0	0	0	0	-1.84K	-35K	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	-4.5M	0	0	0	0	0	0	-14.75M	0	0	0	0	0	0	0	-500K	0	0	0	0
Cash from Financing	0	0	0	0	0	-15.27K	14.54M	-44.63K	94.8M	0	0	0	0	0	0	-102.07K	0	-102.07K	54.23M	-816.92K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	0	0	0	0	0	14.54M	-44.63K	94.8M	0	0	0	0	0	0	0	0	-102.07K	53.41M	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	-44.63K	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	-15.27K	0	0	0	0	0	0	0	0	0	-102.07K	0	0	816.92K	-816.92K
Net Change in Cash	-11.54M	-11.47M	-10.94M	-6.58M	-5.84M	-5.08M	9.63M	-16.73M	91.45M	-4.36M	-7.23M	-3.46M	-4.63M	-5.73M	-3.93M	-3.49M	-2.81M	-3.91M	49.22M	-860.55K
Free Cash Flow	-7.04M	-11.47M	-8.94M	-6.58M	-5.84M	-5.06M	-4.91M	-1.94M	-3.36M	-4.36M	-7.23M	-3.46M	-4.63M	-5.73M	-3.93M	-3.49M	-2.81M	-3.86M	-4.96M	-43.63K
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-20.62%	-126.51%	-82.25%	-239%	-73.89%	-16.09%	32.1%	43.93%	27.54%	23.88%	-83.91%	0.95%	-64.98%	-48.59%	20.8%	-7907.92%	-35.02%	-124.76%	-2718.74%	-
FCF per Share	-0.07	-0.12	-0.10	-0.07	-0.06	-0.05	-0.08	-0.02	-0.06	-0.27	-0.45	-0.22	-0.29	-0.36	-0.25	-0.22	-0.18	-0.24	-0.49	-0.12
FCF Conversion (FCF/Net Income)	0.48x	1.32x	0.69x	0.68x	0.66x	1.10x	1.47x	0.11x	1.49x	1.19x	1.07x	0.59x	0.92x	0.91x	1.10x	0.78x	0.70x	1.11x	1.60x	0.03x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0